Tibet Rhodiola Pharmaceutical Holding Co.
600211Specialty Retail
CN¥35.71−0.78%As of Oct 29vs prior close
- Market cap
- $1.7B
- P/E (TTM)
- 11.7×
- From 52W high
- −21.13%
- EPS (LTM)
- CN¥3.06
- Revenue (LTM)
- CN¥2.9B
- Net margin
- 33.92%
- Dividend yield
- 5.66%
Nomior Score
42
Steady ProfileBottom 33% of the scored universe
Growth52
Quality63
Value50
Momentum1
Resilience66
Growth
+5.29%revenue a year over 3 fiscal years
YE22 CN¥2.6BLTM CN¥2.9B
Connections
Revenue to profitYE25
31% of revenue became net profit, down 6 pts on a year.